3
Dr. Shukla have over 12 years of experience in Viral immunology and developing the antiviral strategies. During his Ph.D. he had designed a recombinant dengue vaccine candidate and established an in-house mouse model (first time in India) to assess the antibody-mediated disease enhancement of dengue vaccine candidates. Later, he transferred this “know-how” to Sun Pharmaceutical Pvt. Ltd. Besides this, he was actively engaged in the anti-dengue botanical drug development program of ICGEB-Sun Phar